I'm surprised to see so little hotcopper activity on this one.
ANP is one of the few uptrending biotechs on the ASX and it is now two months away from releasing phase IIa results on its multiple sclerosis therapy.
It is always worth having a punt when trial results are imminent. Just make sure you close some of your positions prior to the announcement.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.001(5.88%) |
Mkt cap ! $9.786M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 0.9¢ | 0.8¢ | $1.79K | 210K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 10989304 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 1487417 | 6 |
View Market Depth
| Last trade - 16.10pm 16/07/2025 (20 minute delay) ? |
| PER (ASX) Chart |